Silva Ljevar

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (14)

Marta Barisella

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Sandro Pasquali

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Maurizio Colecchia

Professor

Università Vita Salute San Raffaele

ITALY

View details

paolo verderio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Riccardo Valdagni

Associate Professor

University of Milan

ITALY

View details

Giusy Ceparano

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Chiara Monfrini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Valentina Doldi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Giovanni Centonze

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Cristina Marenghi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Paolo Gandellini

Associate Professor

University of Milan

ITALY

View details

Nadia Zaffaroni

Head of Research Unit (Molecular Pharmacology)

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Claudia Sangalli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ANNALISA CHIAPPELLA

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Silva Ljevar

Research Interests

Explore related searches

Contact this professor

Articles (12)

Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis

A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas

Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma

Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer

T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies

Patients Outcome after Chimeric Antigen Receptor (CAR) T-Cells Failure in Aggressive B-Cell Lymphomas: Role of Immunotherapy and Prognostic Factors

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma

Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer

Mammographic density to predict response to neoadjuvant systemic breast cancer therapy

Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem

Collaborators (14)

Marta Barisella

Sandro Pasquali

Maurizio Colecchia

paolo verderio

Riccardo Valdagni

Giusy Ceparano

Chiara Monfrini

Valentina Doldi

Giovanni Centonze

Cristina Marenghi

Paolo Gandellini

Nadia Zaffaroni

Claudia Sangalli

ANNALISA CHIAPPELLA

Make your next move.